Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this 7- to 13-month study is to determine the efficacy of 8 mg/day oral
perindopril to prevent the recurrence of atrial fibrillation (AF) in patients with essential
hypertension.